• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

完全植入式血管通路装置的延长冲洗和锁定间隔:系统评价和荟萃分析。

Prolonged flushing and locking interval for totally implantable vascular access device: A systematic review and meta-analysis.

机构信息

Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

J Vasc Access. 2021 Nov;22(6):969-978. doi: 10.1177/11297298211003003. Epub 2021 Mar 22.

DOI:10.1177/11297298211003003
PMID:33752495
Abstract

The objective of this systematic review is to evaluate the safety ad feasibility of the totally implantable vascular access devices (TIVADs) flushed more than 4 weeks. We searched the following electronic databases from the date their build-up to February 2020: PubMed, EMBASE, The Cochrane Central Register of Controlled Trials (CENTRAL), and CINAHL. The final selection resulted in 14 trials fulfilling the inclusion criteria and being included in our review. A pooled frequency of port-related late complications with longer flushing intervals (>4 weeks) was 8.0%, and the pooled frequency of occlusions, infections, and mechanical complications was 5.0%, 2.0%, and 3.0%, respectively. Then, we compared the frequency of port-related complications between standard and longer flushing intervals. There were no differences between the group's changes in the frequency of total late complications, occlusions, infections, and mechanical complications. This systematic review and meta-analysis demonstrates that longer flushing intervals for ports are safe. However, more prospective, power appropriated randomized trials are needed to explore the specific flushing time for ports.

摘要

本系统评价的目的是评估完全植入式血管通路装置(TIVAD)超过 4 周冲洗的安全性和可行性。我们从建立日期到 2020 年 2 月搜索了以下电子数据库:PubMed、EMBASE、The Cochrane Central Register of Controlled Trials(CENTRAL)和 CINAHL。最终选择了 14 项符合纳入标准并纳入本综述的试验。更长冲洗间隔(>4 周)时与端口相关的晚期并发症的合并频率为 8.0%,而与端口相关的阻塞、感染和机械并发症的合并频率分别为 5.0%、2.0%和 3.0%。然后,我们比较了标准冲洗间隔和更长冲洗间隔之间与端口相关的并发症的频率。两组晚期总并发症、阻塞、感染和机械并发症的频率变化没有差异。本系统评价和荟萃分析表明,延长端口冲洗间隔是安全的。然而,需要更多前瞻性、适当功率的随机试验来探索特定的端口冲洗时间。

相似文献

1
Prolonged flushing and locking interval for totally implantable vascular access device: A systematic review and meta-analysis.完全植入式血管通路装置的延长冲洗和锁定间隔:系统评价和荟萃分析。
J Vasc Access. 2021 Nov;22(6):969-978. doi: 10.1177/11297298211003003. Epub 2021 Mar 22.
2
Extending the interval of flushing procedures of totally implantable vascular access devices in cancer patients: It is time for a change.延长癌症患者全植入式血管通路装置冲洗程序的间隔时间:是时候改变了。
J Vasc Access. 2021 Sep;22(5):689-691. doi: 10.1177/1129729820959928. Epub 2020 Sep 22.
3
Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs).完全植入式静脉通路装置(TIVADs)中延长冲洗间隔的影响。
Br J Nurs. 2018 Apr 26;27(8):S4-S10. doi: 10.12968/bjon.2018.27.8.S4.
4
Prolonging the flush-lock interval of totally implantable venous access ports in patients with cancer: A systematic review and meta-analysis.延长癌症患者全植入式静脉输液港的冲洗锁定间隔:系统评价和荟萃分析。
J Vasc Access. 2021 Sep;22(5):814-821. doi: 10.1177/1129729820950998. Epub 2020 Sep 1.
5
Short Versus Long Timing of Flushing of Totally Implantable Venous Access Devices When Not Used Routinely: A Systematic Review and Meta-analysis.当不完全常规使用时,完全植入式静脉通路装置冲洗的短时间与长时间:系统评价和荟萃分析。
Cancer Nurs. 2021;44(3):205-213. doi: 10.1097/NCC.0000000000000819.
6
Eight-week interval in flushing and locking port-a-cath in cancer patients: A single-institution experience and systematic review.癌症患者中经外周静脉穿刺中心静脉导管冲洗与封管的八周间隔:单机构经验及系统评价
Eur J Cancer Care (Engl). 2019 Mar;28(2):e12978. doi: 10.1111/ecc.12978. Epub 2018 Dec 10.
7
Centrally inserted external catheters and totally implantable ports for the delivery of chemotherapy: a systematic review and meta-analysis of device-related complications.用于化疗给药的中心插入式外部导管和完全植入式端口:与装置相关并发症的系统评价和荟萃分析
Cardiovasc Intervent Radiol. 2014 Aug;37(4):990-1008. doi: 10.1007/s00270-013-0771-3. Epub 2013 Nov 13.
8
Heparin versus 0.9% saline solution to maintain patency of totally implanted venous access ports in cancer patients: A systematic review and meta-analysis.肝素与 0.9%生理盐水在维持癌症患者完全植入式静脉输液港通畅中的比较:一项系统评价和荟萃分析。
Int J Nurs Pract. 2021 Apr;27(2):e12913. doi: 10.1111/ijn.12913. Epub 2021 Jan 22.
9
Comparison between Arm Port and Chest Port for Optimal Vascular Access Port in Patients with Breast Cancer: A Systematic Review and Meta-Analysis.乳腺癌患者最佳血管通路端口的 Arm Port 和 Chest Port 比较:系统评价和荟萃分析。
Biomed Res Int. 2020 Feb 13;2020:9082924. doi: 10.1155/2020/9082924. eCollection 2020.
10
The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.完全植入式中心静脉通路端口的晚期并发症:一项意大利多中心前瞻性观察研究结果。
Eur J Oncol Nurs. 2011 Dec;15(5):377-81. doi: 10.1016/j.ejon.2010.11.007. Epub 2010 Dec 16.

引用本文的文献

1
[Clinical Practice and Quality Control Guidelines for Totally Implantable Venous Access Ports in Cancer Patients (2024)].《癌症患者完全植入式静脉输液港临床实践与质量控制指南(2024年)》
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):400-410. doi: 10.12182/20250360602.
2
Is it feasible to prolong the flushing interval for totally implantable venous access devices (TIVADs)? A systematic review and meta-analysis.延长完全植入式静脉通路装置(TIVADs)的冲洗间隔是否可行?一项系统评价和荟萃分析。
Int J Clin Oncol. 2025 Jan;30(1):40-50. doi: 10.1007/s10147-024-02665-2. Epub 2024 Nov 27.
3
Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review.
肿瘤学中中央静脉通路装置的术语、并发症和移除原因:范围综述。
BMC Cancer. 2024 Apr 19;24(1):498. doi: 10.1186/s12885-024-12099-8.
4
Exploring risk factors for totally implantable venous access devices (TIVADs)-related thrombotic occlusion in the off-treatment period.探讨治疗期结束后完全植入式静脉通路装置(TIVAD)相关血栓性闭塞的危险因素。
Sci Rep. 2023 Jul 4;13(1):10767. doi: 10.1038/s41598-023-37902-7.
5
Safety and feasibility assessment of extending the flushing interval in totally implantable venous access port flushing during the non-treatment stage for patients with breast cancer.乳腺癌患者非治疗阶段完全植入式静脉输液港冲管间隔延长的安全性与可行性评估
Front Oncol. 2022 Dec 2;12:1021488. doi: 10.3389/fonc.2022.1021488. eCollection 2022.
6
Totally Implantable Venous Access Devices: A Randomized Controlled Trial on the Effect of Psychological Support on Quality of Life and Body Image (BI-PORT).完全植入式静脉通路装置:一项关于心理支持对生活质量和身体意象影响的随机对照试验(BI-PORT)。
Front Psychol. 2021 Nov 12;12:703497. doi: 10.3389/fpsyg.2021.703497. eCollection 2021.